We're #hiring a new Director of Regulatory Affairs in Ireland. Apply today or share this post with your network.
Arriello’s Post
More Relevant Posts
-
As Gold sponsor, Arriello is thrilled to support The World Drug Safety Congress Americas on October 29-30, 2024. Join us at the premier event for drug safety and #pharmacovigilance professionals! This is the place where 2,500 #biotech and #pharma leaders come together to address the critical challenges in our industry. https://lnkd.in/eNXUP4yP #WorldDrugSafety
To view or add a comment, sign in
-
#Pharma Acquisitions & Mergers Due diligence is crucial to ensure a smooth and successful deal. Read more on this in our case study: https://lnkd.in/eeDTUETA Here's a glimpse into three key areas we recently focused on. 1. Regulatory & Pharmacovigilance (PV) Due Diligence: 2. Quality Due Diligence of Quality Management System (QMS): 3. Manufacturing Facility Review: We’re here to help take the strain in this critical time and answer your questions. Contact us via [email protected] or DM. #Pharmaceuticals #Privateequity #Duediligence
To view or add a comment, sign in
-
Arriello's very own Sandra Lourenço will be leading a session at #TOPRA Symposium 2024, Europe's premier conference for healthcare #regulatoryaffairs! Sandra will be taking part in session PS1 – Resolving Specific Development Hurdles via Scientific Advice, alongside Andrea Laslop of Austrian Agency for Health and Food Safety, Mireille M. Muller of Novartis, Marianne Lunzer of Austrian Agency for Health and Food Safety and Jane Moseley of the EMA. In this short video (see below), Sandra explains why you can't miss the Symposium in Rotterdam this year (September 30th - October 2nd). Gain the latest insights and developments in #humanmedicines. #TOPRASymposium #TOPRASym24 #Pharmaceuticals
The #TOPRA #Symposium is #Europe’s premier #conference for #healthcare #regulatoryaffairs. Sandra Lourenço is a member of the #HumanMedicines programme #workingparty and one of our many #expertspeakers. Sandra will be taking part in session PS1 – Resolving Specific Development Hurdles via Scientific Advice, alongside Andrea Laslop of AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit, Mireille M. Muller of Novartis, Marianne Lunzer of AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit and Jane Moseley of the European Medicines Agency (EMA). In this short video, she explains why you should join us in #Rotterdam between 30 September and 2 October for the latest industry insights and developments in #humanmedicines, #veterinarymedicines and #medicaldevices / #IVDs. This year, we are hosting the Symposium in partnership with the Medicines Evaluation Board (MEB), the Netherlands' national authority of medicines and health products. Find out more about the Symposium programme and book now 👉 www.topra.org/symposium In addition to discounted rates for TOPRA members, we also offer discounts for those working for regulatory and government agencies, academic institutions, charities, patient groups or in full-time education, and for bulk bookings. #TOPRASym24
To view or add a comment, sign in
11,737 followers